Ticker: PRLD

Company: Prelude Therapeutics Inc

Person: Krishna Vaddi, director, officer

Transaction date: March 14, 2025

Reporting date: March 18, 2025

Average share price: 0.7533521288837745

Bought 39105.0 shares for 29459.84